TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ADCT

ADC Therapeutics SA

Healthcare · Biotechnology

1.30$ +6.1% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Balance Sheet

ADC Therapeutics SA (ADCT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 279 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ADCT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
467 355 308 372 349 322 273 322 290 323 291 279
376 336 290 355 333 307 258 319 287 306 277 262
310 279 234 300 274 251 195 265 235 261 231 219
310 279 234 300 274 251 195 265 235 261 231 219
21 25 23 23 24 20 32 26 23 29 31 28
23 16 16 15 16 18 17 18 18 4.2 4.8 4.9
16
12
521 503 502 503 521 525 511 521 528 509 508 508
78 68 63 58 68 80 58 65 62 70 68 86
16 1.5 1.4 1.4 1.5 1.4 1.4 1.8 0.9 3.0 4.6 6.2
9.0 16 14 11 14 18 16 9.6 8.1 9.2 5.3 13
98 113 113 114 114 114 114 114 115 112 111 110
-54 -148 -194 -132 -172 -203 -238 -199 -238 -186 -216 -228
-1,235 -1,335 -1,382 -1,419 -1,463 -1,493 -1,532 -1,589 -1,630 -1,636 -1,669 -1,685
82 82 83 96 105 105 107 114 136 150 154 155

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?